NEUROLOGY 2008;71:1431-1438 © 2008 American Academy of Neurology
A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation
E. Tunnell, MD, R. Wollman, MD, PhD, S. Mallik, BA, C. J. Cortes, BS, S. J. DeArmond, MD, PhD and J. A. Mastrianni, MD, PhD From the Departments of Neurology (E.T., S.M., C.J.C., J.A.M.) and Pathology, Division of Neuropathology (R.W.), The University of Chicago, IL; and the Department of Pathology, Division of Neuropathology (S.J.D.), UCSF, San Francisco, CA.
Address correspondence and reprint requests to Dr. James A. Mastrianni, Department of Neurology, University of Chicago, Pritzker School of Medicine, 5841 So. Maryland Ave., Chicago, IL 60637 firstname.lastname@example.org
Objective: To define the clinicopathologic, genetic, and pathogenic prion protein (PrPSc) characteristics associated with a novel mutation of the prion protein gene (PRNP).
Methods: The coding segment of PRNP from the proband and family members was sequenced and the brain of the proband was histologically studied. The Western blot profile of the proteinase K (PK) resistant fraction of PrPSc, an approximation of its conformation, or "PrPSc-type," was determined.
Results: We detected a novel mutation at codon 105 of PRNP that results in a serine (S) substitution of proline (P) (P105S), in a young woman who developed progressive aphasia, behavioral changes, dementia, and parkinsonism, lasting 10 years to her death. Histopathologic findings included an intense focus of multicentric PrP-plaques within the hippocampus, punctate plaques scattered throughout the cerebellum, and intense spongiform degeneration focally within the putamen, suggesting a variant of Gerstmann-Sträussler-Scheinker syndrome (GSS). However, PrPSc-typing revealed two PK-resistant PrPSc fragments (21 and 26 kDa), a pattern not previously detected in GSS.
Conclusions: This mutation is the third sequence variation at codon 105 of PRNP. The unusual phenotype and PrPSc-type distinguishes this genetic prion disease from typical Gerstmann-Sträussler-Scheinker syndrome and other codon 105 substitutions, suggesting that, in addition to the loss of proline at this position, the PrPSc conformation and phenotype is dependent on the specific amino acid substitution.
Abbreviations: fCJD = familial Creutzfeldt-Jakob disease; FFI = familial fatal insomnia; FTD = frontotemporal dementia; GSS = Gerstmann-Sträussler-Scheinker syndrome; PK = proteinase K.
Supported by the NIH (NIH R01 NS46037, NIH R01 NS051480); the Brain Research Foundation, Chicago, IL; The John Miko Foundation for Prion Research; and the Pioneer Fund.
Disclosure: The authors report no disclosures.
Received March 18, 2008. Accepted in final form July 16, 2008.
Brain Advance Access published September 1, 2008
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series
HUMAN and ANIMAL TSE Classifications i.e. mad cow disease and the UKBSEnvCJD only theory JUNE 2008
Tissue infectivity and strain typing of the many variants of the human and animal TSEs are paramount in all variants of all TSE. There must be a proper classification that will differentiate between all these human TSE in order to do this. With the CDI and other more sensitive testing coming about, I only hope that my proposal will some day be taken seriously. ...